Last reviewed · How we verify
Echothiophate Iodide 0.03% Ophthalmic Solution — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Echothiophate Iodide 0.03% Ophthalmic Solution (Echothiophate Iodide 0.03% Ophthalmic Solution) — Danbury Eye Physicians & Surgeons, PC.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Echothiophate Iodide 0.03% Ophthalmic Solution TARGET | Echothiophate Iodide 0.03% Ophthalmic Solution | Danbury Eye Physicians & Surgeons, PC | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Echothiophate Iodide 0.03% Ophthalmic Solution CI watch — RSS
- Echothiophate Iodide 0.03% Ophthalmic Solution CI watch — Atom
- Echothiophate Iodide 0.03% Ophthalmic Solution CI watch — JSON
- Echothiophate Iodide 0.03% Ophthalmic Solution alone — RSS
Cite this brief
Drug Landscape (2026). Echothiophate Iodide 0.03% Ophthalmic Solution — Competitive Intelligence Brief. https://druglandscape.com/ci/echothiophate-iodide-0-03-ophthalmic-solution. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab